Dyne Therapeutics

IPO

A biotechnology company developing nucleic acid therapies for rare diseases.

Public · Waltham, United States · Founded 2017 · $165.0M raised

Employees
201–500
Founded
2017
Business Model
B2B
Total Funding
$165.0M
Last Round
$115.0M Series BAug 2020
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Dyne Therapeutics is trailblazing the development of therapies to deliver functional improvement for people living with genetically driven neuromuscular diseases. The company uses its FORCE platform to develop therapeutics that address the root cause of disease by delivering targeted therapies to muscle and the central nervous system. Its pipeline includes clinical programs for Duchenne muscular dystrophy and myotonic dystrophy type 1, plus programs for FSHD, Pompe disease, and additional DMD mutations. Dyne is advancing these nucleic acid therapies so people living with rare neuromuscular disorders can gain meaningful functional improvement.

Summary

Dyne Therapeutics is a Biotech company based in Waltham, United States, founded in 2017. It has raised $165.0M in total across 2 rounds, most recently a $115.0M Series B round in Aug 2020. Investors include Atlas Venture, Hercules Capital and Forbion Capital Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Debt FinancingDebt FinancingJun 2025
$100.0M

Sign up to see all 4 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Dyne Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/dyne-therapeutics"><img src="https://indexed.vc/api/badge/company/dyne-therapeutics" alt="Dyne Therapeutics on Indexed.vc" width="260" height="76" /></a>